With little change in the tampon design for nearly a century, an innovative new design may soon hit the shelves. […]
FDA Clears Sequel’s Tampon

With little change in the tampon design for nearly a century, an innovative new design may soon hit the shelves. […]
Suono Bio’s ultrasound-mediated drug delivery platform shows promising outcomes in its first-in-human study, demonstrating encouraging results. This is the first […]
Visana Health, a 2021 UCSF Rosenman ADAPT Awardee, secured $10.1 million in seed funding. The funding will allow Visana to […]
Enspectra Health, a 2018 Rosenman Innovator and 2022 UCSF Rosenman RISE company pioneering the virtual biopsy, was awarded a $2M […]
Candesant Biomedical has secured a $35M Series B following FDA clearance for their pioneering anti-sweat patch. This financial boost led […]
Pear Suite, a digital health startup, secures $2.5M in seed funding to boost community health workers’ effectiveness and extend its […]
Centese, a Rosenman Innovator and MTVP portfolio company, is proud to announce several significant milestones in the development and clinical utilization of its groundbreaking Thoraguard […]
GT Medical Technologies, a 2018 Rosenman Innovator and MTVP portfolio company, achieved 1000 orders of their GammaTile technology that brings […]
Laguna Health, a 2021 ADAPT Awardee, recently announced its close of a $15 million Series A round co-led by UCSF […]
2022 ADAPT Finalist, Midi Health, closed a $60M Series B funding round, bringing the company’s total funding raised to date […]